us boards, page-3

Reiner -if thats the best post then I am worried

@@@@@While this math is a little "convoluded" I think that NABI now is a cheap way to buy into a succesful antiviral/flu pipeline with a large contract ($230m) to develop laninamivir in the US as a next gen flu vaccine.@@@@@

Better get PC to tell the market that lani is not a vaccine - he did such a wonderful job educating people in Australia that relenza is not a vaccine

Dank - that post was good - it will all come down to the new CEO - I think they should have a panel of respected business leaders OUTSIDE of both Biote and Nabi - to help select the CEO that we have been crying out for.

The new CEO is going to be the catalyst that will get biota out of the viscous circle and get us into the virtuous circle - as mentioned in my 'missed opportunity' post which was a missed post!